Fluticasone Propionate, Salmeterol

5 trials RRespiratory

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

0 Recruiting

3 Completed trials

5 Sponsors

9 Countries

Phase III

Phase II

Phase IV

Phase III: 2 Phase II: 1 Phase IV: 2

Oversight events:

4 temporary halts across 1 trial

View oversight register →

Indications tested

Sponsors using this IMP

Chiesi Farmaceutici S.p.A. 1 Hospices Civils De Lyon 1 Novartis Pharma AG 1 Rapt Therapeutics Inc. 1 Regeneron Pharmaceuticals Inc. 1

All trials

5 total

A double-dummy, double-blind, randomized, active controlled, two-way cross-over study with 12-week treatment duration per period, to evaluat… Pending

2022-502365-26-00 Phase III 4 countries Novartis Pharma AG
A 52 week study in which neither Sponsor or participant know the treatment assigned to subjects to compare the experimental drug (CHF 5993) … Pending

2024-514248-95-00 Phase III 3 countries Chiesi Farmaceutici S.p.A.
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation t… Ended

2023-510458-18-00 Phase IV 3 countries Regeneron Pharmaceuticals Inc.
A Phase 2 study to evaluate the efficacy and safety of RPT193 in adults with moderate-to-severe T2-high asthma who are partially controlled … Ended

2022-502854-16-00 Phase II 3 countries Rapt Therapeutics Inc.
Symptoms control and adhErenCe assessment during treatment with mepolizUmab new pREfilled devices. SECURE Ended

2022-501029-19-00 Phase IV 1 country Hospices Civils De Lyon

Showing 1–5 of 5 trials

← All drugs A–Z